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We previously reported that decreased level of semaphorin 3A 
(Sema3A) induces epidermal hyperinnervation in AD. To defend 
against pathogens, skin contains antimicrobial peptides that are 
induced by inflammation. Reduced induction of antimicrobial 
peptides, including cathelicidin LL-37 and human β-defensins 
(hBDs), in lesional skin of AD patients was suggested to increase 
susceptibility to infections. Here, we investigated the effects of 
antimicrobial peptides, including LL-37 and hBD-1-4, on Sema3A 
expression in normal human epidermal keratinocytes (NHEKs). 
We found that treatment with LL-37, but not hBDs, enhanced 
Sema3A expression. This LL-37-induced Sema3A expression 
was completely inhibited by pertussis toxin, an inhibitor of Gi 
subfamily of G protein α and by PD98059, an inhibitor of ERK1/2 
signaling. Moreover, analysis of LL-37 receptors showed that 
P2X7R may be at least partly involved in LL-37-induced Sema3A 
expression in NHEKs. Thus, in addition to antimicrobial activity, 
cathelicidin LL-37 may contribute to the induction of Sema3A 
expression in NHEKs via certain Gi-coupled receptors and the 
ERK1/2 signaling pathway.
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OVEREXPRESSION OF HISTIDINE 
DECARBOXYLASE IN THE EPIDERMIS OF 
PRIMATES WITH CHRONIC ITCH
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Akiyama
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Recently, an increase in epidermal histidine decarboxylase (HDC), 
a key enzyme for histamine synthesis, has been shown to be 
involved in acute and chronic itch-related behaviors induced by 
topical application of anionic surfactants in mice. Moreover, HDC 
was up-regulated in the epidermis of atopic dermatitis patients. 
These findings suggest the possibility that increased HDC in the 
epidermis plays a role in skin conditions with chronic itch. The 
aim of this study was to investigate whether the expression of 
epidermal HDC is increased in primates with idiopathic chronic 
itch. The skin biopsies were collected form 8 adult female Cyno-
molgus macaques (Macaca fascicularis) with varying degrees of 
idiopathic chronic itch. The expression of HDC was quantified by 
immunohistochemistry and analyzed in a blind manner. A signifi-
cant positive correlation was observed between expression level of 
epidermal HDC and time spent in spontaneous scratching (Pearson 
Correlation, r=0.734, p=0.038). The expression was limited to the 
upper epidermal layers. The up-regulation of HDC in the upper 
epidermis may be involved in skin conditions with chronic itch.
CLINICAL RESEARCH TRACK – 
METHODOLOGY FOR ITCH
PP16
A RELIABILITY ASSESSMENT OF 
STANDARDIZED HUMAN SURROGATE MODELS 
OF HISTAMINERGIC AND NON-HISTAMINERGIC 
ITCH USING HISTAMINE AND COWHAGE 
SPICULES
Hjalte H. Andersen1, Anne-Kathrine R. Sørensen1, Gebbie A. 
R. Nielsen1, Marianne S. Mølgaard1, Pernille Stilling1, Jesper 
Elberling2, Lars Arendt-Nielsen1
1SMI, Department of Health science and Technology, Faculty of Medicine, 
Aalborg University, 2The Allergy Clinic, Copenhagen University Hospital, 
Gentofte, Copenhagen, Denmark 
Recent discoveries in itch neurophysiology have led to an in-
creased use of human surrogate models of both histaminergic 
and particularly non-histaminergic itch. However, no absolute 
or relative reliability assessments have been conducted for these 
models and methods for induction of itch using cowhage are 
highly variable. This study sought to standardize cowhage 
application and to perform a test–retest reliability-assessment 
for the application of both histamine and cowhage. 3 doses of 
cowhage (5, 15 and 25 spicules), and 1 dose of 1% histamine 
were applied in 4 areas on the volar forearm in 15 healthy male 
volunteers. All measurements were performed twice, 7.73 days 
(±0.73 SEM) apart. Itch- and pain-intensity were rated on a co-
VAS. Spatial itch distribution, TEWL and blood perfusion were 
monitored. Measures of reliability were coefficient of variation 
(CV) and intra-class correlation (ICC) for each itch provocation. 
Stimulus-response-associated differences were found between 
doses for the intensity of itch and the peak itch intensity (p<0.05). 
The reliability assessment for the itch intensity exhibited good 
intra-individual reliability (ICC = 0.57–0.83) and modest absolute 
reliability (CV = 25.4–156.6) for both cowhage and histamine-
induced itch. Quantification of the spatial perception of itch 
exhibited low reliability.
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Clinically, atopic dermatitis (AD) associated pruritus is resistant to 
conventional treatment, including histamine H1 receptor antago-
nists. Granzymes (Gzms), a family of serine proteases expressed 
by cytotoxic T lymphocytes and natural killer cells, have been 
shown to modulate inflammation. Their relationship with pruri-
tus of AD still remains unclear. In the present study, we assessed 
relationships among plasma Gzm levels and severity of pruritus 
or dermatitis in AD patients. In enzyme-linked immunosorbent 
assays, plasma GzmB levels were significantly increased in AD 
patients. Correlation analyses among other clinical markers of 
AD showed that plasma GzmB levels positively correlated with 
plasma gastrin releasing peptide (GRP) level, serum thymus and 
activation-regulated chemokine (TARC) levels or scoring atopic 
dermatitis (SCORAD). Visual analogue scale (VAS) score also 
tended to correlate with plasma GzmB level. On the other hand, 
plasma GzmA levels showed no correlation with these clinical 
markers. These data suggest that plasma GzmB levels may be 
involved in the severity levels of both pruritus and dermatitis in 
AD patients.
